Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now

Key Takeaways OPKO Health is positioned for growth with RAYALDEE performance and multiple partnership-driven initiatives.RAYALDEE maintained sales strength supported by rebates, discounts and broad U.S. distribution channels.Clinical programs advanced with new oncology, vaccine and metabolic trials and continued data presentations.OPKO Health, Inc. (OPK) is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s perfor ...